Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine

International Journal of Clinical Pharmacology Research

Volumn 19, Issue 2, 1999, Pages 57-64

  Pini, Luigi Alberto ^b   Fabbri, L ^a   Cavazzuti, L ^a  

^a GSK   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; BUTALBITAL; CAFFEINE; INDOMETACIN; OPTALIDON; PARACETAMOL; PHENYLBUTAZONE; PROCHLORPERAZINE; SUMATRIPTAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFMETRE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADOLESCENT; ADULT; AGED; ANALGESICS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; HUMANS; ITALY; MIDDLE AGED; MIGRAINE DISORDERS; NAUSEA; RECURRENCE; SEROTONIN AGONISTS; SUMATRIPTAN; VOMITING;

EID: 0033377840     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Welch K.M. Drug therapy of migraine. N. Engl. J. Med., 329(20), 1476, 1993.
2. Linee guida e raccommandazioni per il trattamento dell'emicrania. Confinia Cephalalgica, 8, 73, 199.
3. Pfaffenrath V., Cunin G., Sjonell G., et al. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine. Defining the optimum doses of oral sumatriptan. Headache, 38, 184, 1998.
4. Henry P., Hiesse-Provorst O., Dillenscheider A., Garny H., Insuasty J. Efficacy and tolerance of effervescent aspirin-metoclopramide association in the treatment of migraine attack. A randomised, double blind, placebo-controlled study. Press Med., 24, 254, 1995.
5. Chabriat H., Joire J.E., Danchot J., et al. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: A multicentre double-blind placebo-controlled study. Cephalalgia, 14, 297, 1994.
6. Dahlof C., Bjorkman R. Diclofenac (50 and 100 mg) and placebo in the acute treatment of migraine. Cephalalgia, 13, 117, 1993.
7. Treves T.A., Streiffer M., Korczyn A.D. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks. Headache, 32, 280, 1992.
8. Davis C.P., Torre P.R., Williams C., et al. Ketorolac vs meperidine plus promethazine treatment of migraine headache: evaluation by patients. Am. J. Emerg. Med., 13, 146, 1995.
9. Larkin GL, Prescott JE. A randomized double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med; 21: 919; 1992.
10. Nappi G., Micieli G., Tassorelli C., et al. Effectiveness of a piroxicam fast dissolving formulation sublingually administered in the symptomatic treatment of migraine without aura Headache, 33, 296, 1993.